Search

everythinglearnresearchcommunity

for

Search:↓

Long-COVID symptoms like fatigue, cognitive issues, and mobility problems can last 6-12 months but are less common after milder illness.

Skin issues in PCOS worsen quality of life and are linked to hormonal imbalances.

Vitiligo causes significant emotional stress in Africa, the Middle East, and Latin America, with limited treatment options available.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

People with mycosis fungoides/Sézary syndrome have a much lower quality of life.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

Men have more severe COVID-19 outcomes than women.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

The guideline offers practical advice for diagnosing and treating Post-COVID/Long-COVID.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Alopecia areata treatment varies, with no optimal method established yet.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.